Commentaries are short perspectives by experts on AJKD articles or nephrology news.

Clinical Trial End Points in ADPKD

June 6, 2019 // 0 Comments

Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. There has been recent interest in redefining end points for clinical trials [read more...]

Congo Red: From Amyloid to Aspirin

May 29, 2019 // 1 Comment

Congo red is synonymous with amyloidosis. The visually stunning apple green birefringence lights up the eyes and minds of pathologists and nephrologists. Like many histological stains, Congo red was originally a textile dye that was later used to [read more...]